OTC : BMXMF

bioMérieux S.A.

$78.99 USD

$0 (0.0%)

Volume
66
Average Volume
214
Market Capitalization
$9.32B
P/E Ratio
17.58
Dividend Yield
1.42%
Price Target
Year High
$152.00
Year Low
$77.00
Day High
—
Day Low
—
Payout Ratio
$0.25
Current Ratio
$2.30
Company Overview

OTC

Pierre Boulud

Medical - Diagnostics & Research

Healthcare

BMXMF

14147

FR

USD

https://www.biomerieux.com

33 4 78 87 20 00

N/A

N/A

Liquidity Metrics

0.10

2.30

1.44

0.58

0.25

Sales & Valuation

$4.07B

2.04

1.89

13.92

4.97

Profitability

$3.34

$397.35M

11.59%

15.21%

11.01%

8.12%

P/E Metrics

17.58

0.77

0.77

Analyst Price Target & Rating

Buy

4/5

5 Analysts

%

Financial Health Scores

5.90

8/9

$1.47B

$5.69B

$1.39B

$1.14B

Key Metrics (TTM)

$7.92B

1.98

8.63

2.30

11.01%

7.59%

5.68%

7.18%

$56.78

226 days

Company Executives
Name Title
Guillaume Bouhours Executive VP of Finance, Purchasing and Information Systems & CFO
Valerie Leylde Executive Vice President of Human Resources, Communications & CSR
Charles K. Cooper Executive VP of Medical Affairs & Chief Medical Officer
Frederic Beseme Head of CSR
Pierre Boulud Chief Executive Officer
Pierre Charbonnier Executive Vice President of Global Quality, Manufacturing & Supply Chain
Yasha Mitrotti Executive Vice President of Industrial Applications
Audrey Dauvet Executive Vice President of Legal, Corporate Integrity & Public Affairs
Celine Roger-Dalbert Executive Vice President of Research & Development
Jennifer Zinn Executive Vice President of Clinical Operations
Poll Results

No votes yet today — be the first to share your view!

About bioMérieux S.A. (OTC:BMXMF) Stock

Operating on a global scale, bioMérieux S.A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The firm's offerings encompass diagnostic systems that analyze biological samples to identify infectious diseases, cardiovascular conditions, and various types of cancer. Furthermore, it provides essential microbiological testing for quality assurance within the food, pharmaceutical, cosmetics, and veterinary industries. Its diverse clientele includes clinical and hospital laboratories, medical professionals, blood banks, and industrial control facilities. Founded in 1963, initially under the name B-D Mérieux, bioMérieux S.A. is headquartered in Marcy l'Etoile, France, and funct ... ions as a subsidiary of Institut Mérieux SA.

Frequently Asked Questions

What is the current bioMérieux S.A. (BMXMF) stock price?

bioMérieux S.A.(OTC:BMXMF) stock price is $78.99 in the last trading session. During the trading session, BMXMF stock reached the peak price of $152 while $77 was the lowest point it dropped to. The percentage change in BMXMF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BMXMF stock was $0.

BMXMF's industry and sector of operation?

The OTC listed BMXMF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of BMXMF?

Guillaume Bouhours | Executive VP of Finance, Purchasing and Information Systems & CFO
Valerie Leylde | Executive Vice President of Human Resources, Communications & CSR
Charles K. Cooper | Executive VP of Medical Affairs & Chief Medical Officer
Frederic Beseme | Head of CSR
Pierre Boulud | Chief Executive Officer

How many employees does BMXMF have?

Number of BMXMF employees currently stands at 14147. BMXMF operates from 376 Chemin De l’Orme, Marcy l'Étoile, ARA 69280, FR.

Link for BMXMF official website?

Official Website of BMXMF is: https://www.biomerieux.com

How do I contact BMXMF?

BMXMF could be contacted at phone #33 4 78 87 20 00 and can also be accessed through its website. BMXMF operates from 376 Chemin De l’Orme, Marcy l'Étoile, ARA 69280, FR.

How many shares of BMXMF are traded daily?

The average number of BMXMF shares traded daily for last 3 months was 214.

What is the market cap of BMXMF currently?

The market value of BMXMF currently stands at $9.32B with its latest stock price at $78.99